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Detection of subclonal L1 
transductions in colorectal cancer 
by long-distance inverse-PCR and 
Nanopore sequencing
Barun Pradhan1,2, Tatiana Cajuso1,3, Riku Katainen1,3, Päivi Sulo1,3, Tomas Tanskanen1,3, Outi 
Kilpivaara1,3, Esa Pitkänen  1,3, Lauri A. Aaltonen1,3,4, Liisa Kauppi1,2 & Kimmo Palin  1,3
Long interspersed nuclear elements-1 (L1s) are a large family of retrotransposons. Retrotransposons 
are repetitive sequences that are capable of autonomous mobility via a copy-and-paste mechanism. 
In most copy events, only the L1 sequence is inserted, however, they can also mobilize the flanking 
non-repetitive region by a process known as 3′ transduction. L1 insertions can contribute to genome 
plasticity and cause potentially tumorigenic genomic instability. However, detecting the activity 
of a particular source L1 and identifying new insertions stemming from it is a challenging task with 
current methodological approaches. We developed a long-distance inverse PCR (LDI-PCR) based 
approach to monitor the mobility of active L1 elements based on their 3′ transduction activity. LDI-PCR 
requires no prior knowledge of the insertion target region. By applying LDI-PCR in conjunction with 
Nanopore sequencing (Oxford Nanopore Technologies) on one L1 reported to be particularly active 
in human cancer genomes, we detected 14 out of 15 3′ transductions previously identified by whole 
genome sequencing in two different colorectal tumour samples. In addition we discovered 25 novel 
highly subclonal insertions. Furthermore, the long sequencing reads produced by LDI-PCR/Nanopore 
sequencing enabled the identification of both the 5′ and 3′ junctions and revealed detailed insertion 
sequence information.
Long interspersed nuclear elements (LINE)-1, also known as L1 elements, are active mobile repeat elements in the 
human genome. Germline L1 polymorphic insertions are suggestive of L1’s contribution to genomic diversity1. 
Nevertheless, somatic L1 insertions can drive tumorigenesis and high L1 expression is emerging as a common 
trait of several cancers2. For an L1 to be potentially active, it needs to be a full-length element with a 5′ promoter 
and two intact open reading frames, ORF1 and ORF2, terminating with a 3′ polyadenylation signal.
Out of more than 500,000 copies of L1 sequences in the human reference genome only 90 to 100 are poten-
tially active3,4. Upon activation, the L1 is transcribed into an RNA intermediate, which is then translated into two 
proteins, ORF1p and ORF2p. The L1 mRNA, ORF1p and ORF2p form a ribonucleoprotein complex that nicks 
the DNA at the target location via the endonuclease function of ORF2p. The polyadenylated 3′ end of the L1 
mRNA anneals to the T-rich region of the target site, which then acts as a primer for reverse transcription5. Thus, 
this process, referred to as target-primed reverse transcription (TPRT), integrates L1 sequence into the target 
region with a signature polyA sequence marking initiation of reverse transcription. TPRT sometimes is accom-
panied by a process called twin-priming that leads to inversion of the L1 inserts. This results when one overhang 
produced on the target region by ORF2p-mediated staggered double-strand cleavage serves as a T-rich or polyT 
primer for TPRT, and the other anneals to the internal L1 mRNA sequence serving as an internal primer6.
Not all potentially active L1 elements contribute equally to retrotransposition events however, and only few 
“hot” L1 elements are responsible for most retrotranspositions3. These hot L1 elements are of considerable interest 
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as they show frequent somatic insertions in various types of cancers (Fig. 1a)7–11. Particularly, an L1 located in 
the first intron of TTC28 (chromosomal position 22q12.1) (L1Base ID: 13512; dbRIP ID: 200014413), also shown 
to be an active element in an in vitro retrotransposition assay3, is highly active in colorectal cancer9,11. It was 
Figure 1. LDI-PCR based method to detect the activity of a hot L1. (a) Schematic showing mobility of hot L1 
from the TTC28 locus upon activation. (b) LDI-PCR to detect 3′ transduction arising from the L1 at TTC28: 
Schematic representation of a hypothetical TTC28 specific L1 retrotransposition including transduction of 3′ 
flanking region or the “unique tag” (=region between the canonical polyadenylation signal and an alternative 
polyadenylation signal downstream), into an unknown target locus. NsiI produces restriction fragments of two 
different sizes that are self-ligated to form a circular template. Upon LDI-PCR, an inverse primer pair directed 
at the unique tag produces a native product and an insertion-specific target product. In addition to NsiI, two 
further restriction enzymes (PstI and SacI) and primer pairs (not depicted here) were used; see Materials and 
Methods for details.
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possible to identify this particular L1 (hereafter referred to as TTC28 L1) as the source of the insertions by using 
short paired-end read sequencing based on the mobilization of its non-repetitive (unique) 3′ flanking sequence, 
via a mechanism known as 3′ transduction14. 3′ transduction occurs when the canonical 3′ polyadenylation sig-
nal of the source L1 is weak, causing the transcription machinery to skip it and to continue transcribing the 
non-repetitive region downstream in the 3′ flanking region until it reaches a stronger polyadenylation/termina-
tion signal. Consequently, some of this unique sequence is included in the RNA intermediate and subsequently 
incorporated into the new chromosomal location, thereby serving as a unique sequence tag that reveals the L1’s 
origin.
Although whole genome sequencing (WGS) can identify 3′ transductions, detecting these L1-mediated inser-
tions is still a great challenge, principally due to the repetitive nature of L1 sequences and our limited capacity to 
sequence long fragments of DNA. Several next-generation sequencing strategies targeting young L1s or 3′ trans-
duced regions have been developed (ATLAS15, L1-seq.16, RC-seq.17, transduction-specific ATLAS18, TIP-seq.19) 
and used to identify somatic L1 insertions, but they are quite extensive if the aim is to simply assess the activ-
ity of a few L1 loci. Furthermore, all current methods targeting L1 insertions are limited in their capacity to 
simultaneously resolve full insertion sequence. Thus we have developed a direct molecular approach to detect 3′ 
transductions from specific L1s and hence monitor their activity; this method requires no prior knowledge of the 
insertion target regions. We apply long-distance inverse (LDI)-PCR20 to a particular source L1 (TTC28 specific 
L1 in this study) by targeting inverse primers to its frequently transduced 3′ flanking sequence (here referred to as 
the “unique tag”) (Fig. 1b). Note, however, that L1 insertions exhibiting 3′ transduction represent a quarter of the 
total L1 insertions emanating from any particular source11.
We utilized previously published WGS data21 to select two colorectal tumour samples with high number 
of TTC28 L1 3′ transductions (hereafter referred simply as insertions) for our proof-of-concept analysis and 
comparison. By selective amplification of the transduced region using LDI-PCR (Fig. 1b) followed by Nanopore 
sequencing, we were able to detect 14 out of 15 previously detected insertions, and additionally identified several 
highly subclonal insertions not detected by WGS. Long reads produced by Nanopore sequencing allowed detailed 
sequence analysis of the LDI-PCR products, including full inserted sequence and identification of hallmarks of 
retrotransposition, such as target-site duplications and deletions, polyA sequence and genomic aberrations such 
as inversions and deletions22.
Results
Detection of somatically acquired TTC28 insertions using LDI-PCR/Nanopore sequencing. We 
selected the L1 located in the first intron of TTC28 for LDI-PCR analysis, as it had been previously reported to be 
highly active in colorectal cancer9. We performed LDI-PCR (Fig. 1b) on DNA obtained from two tumour sam-
ples, selected from a previously reported WGS data set21 and on DNA from the corresponding normal samples, 
using three restriction enzymes (PstI, NsiI (Fig. 1b) and SacI) and three different primer pairs (Supplementary 
Table S1). The LDI-PCR product corresponding to the source TTC28 L1 (the “native PCR product”) was observed 
in almost all the samples digested with PstI and SacI (Fig. 2) but only sporadically observed in NsiI digested 
samples (e.g. as seen in LDI-PCR using primer pair 2, Fig. 2). In addition to the native PCR product, tumour sam-
ples exhibited additional PCR products which indicated mobilization of the TTC28-specific unique tag via L1 3′ 
transduction to different target locations. In order to identify the target location of each insertion, we sequenced 
the LDI-PCR products from the tumour samples using a single-molecule sequencing technique, Nanopore 
sequencing.
Nanopore sequencing generated 644,669 reads and no bias in read frequency towards particular read lengths 
was apparent (Supplementary Fig. S1). We developed and applied the LDI-PCR software (LDI-PCR.py) to iden-
tify TTC28 specific 3′ transductions in both tumour samples (c985T and c368T). After filtering the LDI-PCR.
py calls, we were able to identify 14 out of 15 previously detected insertions. Additionally, we detected 25 novel 
insertions not identified by WGS, despite visual inspection of the paired-end read data (Supplementary Fig. S2) 
(Table 1). Notably, these 25 novel candidate insertions were supported by fewer reads than the 14 WGS-detected 
insertions (p = 2.43 × 10−6 by Wilcoxon rank-sum test) (Table 1 and Fig. 3). The median number of supporting 
reads was 98 for novel candidate insertions and 11,428 for WGS-detected insertions, suggesting that the novel 
insertions are subclonal events and therefore difficult to detect by 40x WGS.
In order to validate the novel candidate insertions, we first performed conventional PCR and Nanopore 
sequencing and were able to validate two insertions (Y:15633117 and 14:79638932). Subsequently we performed 
allele-specific PCR and Sanger sequencing on another ten insertions, of which we successfully sequenced the 
insertion-to-target junctions for six of them (Table 1, Supplementary Fig. S2). Again, non-validated insertions 
were supported by fewer reads as compared to validated insertions (p = 7.53 × 10–4 by Wilcoxon rank-sum test) 
(Fig. 3). Furthermore, the insertion located at Y:15633117 was confirmed with both methods.
Analysis of consensus sequence generated by LDI-PCR/Nanopore sequencing to elucidate 
insertion characteristics. Consensus sequences, generated from the LDI-PCR.py calls after filtering, pro-
vided us with complete inserted sequences for 35 out of 39 L1 insertions which were analysed to decipher the 
insertion mechanism and retrotransposition hallmarks (Table 1). 8/35 consensus sequences contained short 
alignment gaps, ranging from 3–10 bp, due to mismatches affecting the alignment. Most of these alignment 
gaps (7) arose from insertions supported by less reads indicating, as expected, that higher number of reads 
improves consensus accuracy. 29 out of 35 insertions involved a target-site duplication while 6 insertions involved 
a target-site deletion. We also detected 2 target-site duplications and 1 target-site deletion in insertions with 
incomplete sequence (Table 1). The size of L1 insertions ranged from 142 bp to 1124 bp with an average inser-
tion size of 493 bp. All detected L1 insertions were heavily truncated at their 5′ end, the majority (~77%) to 
the extent that they were composed of the 3′ transduced region only, without any L1 sequence (also known as 
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“orphan transductions”). We were able to locate the terminal sequence in all 35 insertions with complete inserted 
sequence. Variation in the 3′ most genomic coordinate (Table 1) of the L1 3′ transduction suggested the use of 
more than one polyadenylation signal. By following the criteria explained in the methods section to determine 
Figure 2. Agarose gel image of the LDI-PCR products. LDI-PCR using three different inverse primer pairs 
and restriction enzymes on two colorectal tumours (c985T and c368T) and their matching normal (c985N 
and c368N) DNA samples. The “native” PCR product of expected size and several additional tumour-specific 
products representing different putative 3′ transduction targets were detected. (Sizes corresponding to native 
LDI-PCR products: PstI~6.3 kb, NsiI~10.2 kb, SacI~5.6 kb.) Digested/self-ligated blood genomic DNA sample of 
an unrelated individual was run in the lane labelled “b” and PCR without any template in “−”.
www.nature.com/scientificreports/
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which polyadenylation signal was preferred, we observed that more than 90% of the TTC28 L1 3′ transductions 
used either the 6th or the 9th polyadenylation signal instead of the canonical polyadenylation signal (Fig. 4, 
Supplementary Table S2). Preference for the 9th polyadenylation signal is in agreement with polyadq prediction23 
(Supplementary Table S2), a web-based polyadenylation signal prediction tool. However, the 6th polyadenylation 
signal was defined as a false signal by polyadq, even though it had the highest score among the ATTAAA polyade-
nylation signals (Supplementary Table S2).
Strand inversion of the inserted sequence due to twin-priming was observed in 16 out of 35 insertions for 
which complete inserted sequence was available. One more twin-priming event was observed in three insertions 
Sample















count5′ junction 3′junction start end
c985T
1:195769724 1:195769709 intergenic dup. 16 29065826 29066121 + Present 295 3984 yes yes 15
4:93280482 4:93280454 GRID2 dup. 28 29065650 29065893 + Absent 243 4658 no yes 20
4:155900401 4:155900387 intergenic dup. 14 29064889 29065912 + Present 1015 1705 no yes 9
4:183051382 4:183051401 AC108142.1 del. 18 29065306 29065448 − Absent 142 10103 no yes 8
7:146783241 7:146783223 CNTNAP2 dup. 18 29065369 29065912 − Present 536 19889 no yes 29
7:152661949 7:152661940 intergenic dup. 9 29065283 29065887 − Present 455 20107 no yes 19
12:33708291 12:33708277 intergenic dup. 14 29065722 29066121 − Present 377 16909 no yes 20
2:78612537 2:78612530 intergenic dup. 8 29065453 29066118 − Present 665 5 no no 0
3:99147126 3:99147111 intergenic dup. 16 29065138 29066126 − Present 984 47 no no 0
4:90987152 4:90987149 intergenic dup. 4 29065287 29066121 + Absent 834 99 no no 0
6:74978206 6:74978187 RP11–554D15.1 dup. 20 29065521 29066118 + Absent 597 9 no no 0
8:111856478 8:111856457 intergenic dup. 22 29064270 29066083 − Present 857 6 no no 0
14:99070525 14:99070523 intergenic dup. 3 29065558 29065912 − Absent 354 55 yes no 1
16:26220799 16:26220798 intergenic dup. 2 29065976 29066118 + Absent 142 182 no no 0
16:5902138 16:5902158 RP11–420N3.2 del. 19 29065747 29065912 − Absent 165 72 no no 1
c368T
1:115147190 1:115147187 DENND2C dup. 4 29065647 29065893 − Absent 246 12753 no yes 18
2:182004540 2:182004515 AC104820.2 dup. 26 29065285 29065886 + Present 783* 20217 no yes 12
2:229159082 2:229159075 intergenic dup. 8 29065578 29065908 − Absent 330 704 no yes 16
6:70787202 6:70787188 COL19A1 dup. 15 29065808 29066032** NA Present >223 17007 no yes 21
6:133527459 6:133527443 intergenic dup. 17 29065683 29065887 − Absent 204 98 no yes 9
8:88681299 8:88681304 AF121898.3 del. 4 29065471 29065887 + Absent 416 1095 no yes 6
12:128116403 12:128116405 RP11–526P6.1 del. 1 29065730 29066121 − Absent 391 15099 no yes 10
2:50947578 2:50947612 NRXN1 del. 33 29065849 29066032** NA NA >183 98 no no 0
2:129889238 2:129889240 intergenic del. 1 29065945 29066121 − Absent 176 193 no no 0
4:44621421 4:44621515 intergenic del. 93 29065305 29065912 − Absent 607 33 no no 0
5:8665955 5:8665942 intergenic dup. 14 29065849 29066091 + Absent 242 451 yes no 0
5:83347372 5:83347360 EDIL3 dup. 13 29065762 29066121 + Present 340 78 no no 0
5:119565858 5:119565843 intergenic dup. 16 29065419 29065899 + Present 455 14 no no 0
6:112763097 6:112763084 intergenic dup. 14 29065288 29066118 + Present 671 38 no no 0
7:152870668 7:152870685 intergenic del. 16 29065491 29065912 − Present 306 457 yes no 0
8:114925191 8:114925178 intergenic dup. 14 29064763 29065887 − Absent 1124 1020 yes no 0
8:107979180 8:107979169 intergenic dup. 12 29064270 29066121 − Present 1055 28 no no 0
10:101386670 10:101386662 intergenic dup. 9 29065621 29065782** NA NA >161 36 no no 0
10:107557372 10:107557435** intergenic NA NA 29065912 29066032** NA NA >120 86 no no 1
12:33100097 12:33100084 intergenic dup. 14 29065445 29066118 − Present 670 248 yes no 0
14:79638932 14:79638931 NRXN3 dup. 2 29065974 29066121 − Absent 147 172 yes no 1
18:1233989 18:1233975 intergenic dup. 15 29065387 29066121 − Present 735 117 no no 0
X:108351909 X:108351907 intergenic dup. 3 29065437 29065893 − Absent 456 119 no no 0
Y:15633117 Y:15633103 intergenic dup. 15 29065877 29066121 − Absent 244 1084 yes no 1
Table 1. Insertions detected by LDI-PCR/Nanopore sequencing. Note that one insertion was predicted by 
WGS but not by LDI-PCR/Nanopore and not included in the table. TSM = target-site modification; TP = twin-
priming; del. = deletion; dup. = duplication; Read count = Number of LDI-PCR.py reads supporting each 
insertion, if one insertion was detected by more than one enzyme or primer pair, only the reaction with higher 
number of reads was included; *includes internal duplication; **some sequence was missing.
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with incomplete sequence (Table 1). Furthermore, the point of inversion was identifiable in all 16 cases of 
twin-priming. We were able to resolve the 5′ junction for 29 out of 35 L1 insertions, as remaining 6 contained 
short alignment gaps as mentioned earlier. In addition we were also able to resolve 5′ junction of 4 insertions that 
had incomplete inserted sequence. Out of these total 33 insertions 28 of them showed microhomology of 1–13 
bp at the 5′ junction. Microhomology of 1–5 bp was also observed in 10 out of 16 twin-priming inversion point.
We then used information on the inserted sequences to better understand the integration process of the 
L1-derived sequence. To extrapolate the stepwise mechanism of L1 insertion, we selected two insertions dis-
playing two different well-characterized modes of insertion: (a) TPRT, exemplified by the L1 insertion at GRID2 
locus on chromosome 4 and (b) TPRT with twin-priming, exemplified by the L1 insertion at CNTNAP2 locus 
in chromosome 7 (Supplementary Fig. S3, Fig. 5). L1-transduced sequence was inserted on the “+” strand of 
GRID2 target locus and on the “−” strand of CNTNAP2 locus (Supplementary Fig. S3). Target site duplication 
(TSD) observed at both loci indicated L1 endonuclease mediated staggered double-stranded cleavage in the tar-
get region (Fig. 5ai,bi). This staggered double-strand cleavage at both target loci generated a T-rich overhang. 
We infer that these T-rich overhangs produced on the “−” and “+” strand of GRID2 and CNTNAP2 target loci, 
respectively, annealed to the polyA tail at the end of the L1 mRNA (Fig. 5aii,bii) and were used as a polyT primer 
for reverse transcription Fig. 5ai,bi; stepwise mechanism illustrated in Fig. 5aiii,biii). In addition to polyT prim-
ing, reverse transcription at the CNTNAP2 target locus most likely also used as an internal primer the other 
overhang generated, causing an inversion of the inserted sequence (Fig. 5biii). Upon close examination we found 
that the region of inversion (22:29,065,715–29,065,721) did in fact show nucleotide complementarity with the 5′ 
overhang generated by ORF2p on the reverse strand (7:146,783,223) (Fig. 5bii,biii). This twin-priming (first by a 
polyT primer and then by an internal primer) at the CNTNAP2 locus led to reverse-transcription at two different 
Figure 3. Read counts for insertions called by LDI-PCR.py. On the left, boxplots of read counts for insertions 
that were either detected (n = 14) or undetected (n = 25) by WGS. On the right, boxplots of read counts 
for insertions undetected by WGS that were either validated (n = 7) or unvalidated (n = 18). For better 
visualization, data are presented on a base-10 log scale.
Figure 4. Polyadenylation signal of choice for TTC28 L1 mediated 3′ transduction. 8 polyadenylation signals 
following the L1 canonical polyadenylation signal (no. 2–9) were present in the unique tag assessed for TTC28 
L1 3′ transduction. Most of the 3′ transductions identified in this study terminated utilizing the 6th and 9th 
polyadenylation signal instead of the L1’s canonical polyadenylation signal (no. 1). The height of the orange 
bars indicates the frequency of L1 3′ transductions terminating at each polyadenylation signal; number of 
termination events is given above the bars.
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Figure 5. Extrapolated mechanism of L1 insertion at (a) GRID2 locus and (b) CNTNAP2 locus In both (a) 
and (b) (i) shows locations of staggered double-stranded cleavage in the target region with PolyT primer in 
the 3′ overhang and an internal primer (when used) in the 5′ overhang (b). (ii) Extrapolated L1 mRNA with 
the TTC28 3′ unique tag. Regions complementary to the polyT primer and internal primer at target site is 
highlighted by the same colour scheme. (iii) Schematic representation of the TPRT (a) and twin-priming (b) 
mechanism of TTC28 specific 3′ transduction in the GRID2 (a) and CNTNAP2 (b) locus. Figures are not drawn 
to scale.
www.nature.com/scientificreports/
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locations causing strand inversion (Fig. 5biii and biv). We also observed a deletion of 3 base pairs (22:29,065,722–
29,065,724) at the inversion site and microhomology of 3 base pairs between the reverse transcribed sequence 
produced by the polyT primer and the internal primer at the point of inversion (Fig. 5b). Microhomology was 
also observed at the 5′ junction of L1 insertion at the GRID2 target locus. Thus, LDI-PCR/Nanopore sequencing 
provided complete information for most of the somatic L1 insertions, enabling us to analyse the insertion process 
in great detail.
Comparison of the local assembly of WGS data and the consensus sequences generated by 
LDI-PCR/Nanopore sequencing. In order to interpret the advantages and disadvantages of long read 
sequencing, we compared the local assembly of paired-end read data to the LDI-PCR/Nanopore consensus 
sequences of those insertions in tumour sample c985T that were detected by both methods. After local assembly, 
we were able to reconstruct four out of seven insertions into one contiguous fragment (contig) (Supplementary 
Table S3) with defined parameters (Supplementary Table S4). However, the remaining three insertions were rep-
resented in two contigs and therefore the sequence in between was lost. The length of missed sequences, ranging 
from 88 bp to 614 bp, was estimated based on the genomic coordinates of both insertion junctions. However, in 
cases where the twin priming point of inversion was located within the missed sequence, estimation of the inser-
tion size was not possible, as shown for chr7:152661937 (Supplementary Table S3). All insertions with missing 
sequence information were longer than 400 bp and were the longest insertions based on the consensus sequence 
analysis of Nanopore data. The deviation of the estimated length of the insertions ranged from 0–7 bp and 10/14 
target coordinates were consistently predicted by both analysis (Supplementary Table S3). The remaining four 
target coordinates were located right after a tract of Ns where the consensus polyA/T junction was predicted, 
henceforth, target sequence after the polyA/T was probably missed by the local assembly. In conclusion, local 
assembly of paired-end read data was of limited value in reconstructing full insertions but also interpreting pol-
yA/T tails in our study, thus hampering the elucidation of insertion features.
Discussion
Due to the repetitive nature of L1 elements and their abundance in the human genome, it is possible to deter-
mine the lineage or source of the L1 insertions either (a) when the insertion contains signature single nucleotide 
polymorphisms associated with the source L110 or (b) when it involves 3′ transduction of the unique flanking 
sequence9,11. Thus, in order to determine the activity of a particular source L1, one needs to scan the genome of 
interest for either of the aforementioned signs. Assessing the activity of a particular source L1, in particular when 
active in a tumour type, can be of great interest, as these L1 insertions can cause tumorigenic events or serve as a 
clinical biomarker24. However, the specific detection of L1 3′ transductions and/or sequencing the whole length 
of L1 insertions remains a great challenge. In this study we used a LDI-PCR based assay to study the activity of 
a source L1 at the TTC28 locus, previously shown to be highly active in colorectal cancer, and tested it on two 
colorectal cancer samples with already published whole genome sequencing data21.
By applying LDI-PCR in conjunction with Nanopore sequencing to as low as 300 ng of tumour DNA per 
sample, we were able to detect 14 out of 15 previously identified TTC28 L1 mediated 3′ transductions, and also 
discovered 25 3′ transductions not detected by WGS (Table 1). The read count difference between the two groups 
(WGS-detected versus not detected) indicated that these insertions could be subclonal events and thus not detect-
able with 40x sequencing. Furthermore, high coverage provided us with enough data to reconstruct accurate con-
sensus sequences, which permitted analyses of full inserted sequence in 90% of the insertions. About 45% of the 
3′ transductions analysed showed strand inversion due to twin-priming. We speculate that this high incidence of 
twin-priming in TTC28 L1 3′ transduction is due to (a) the nature of nucleotide sequence downstream of the L1 
3′ end, possibly due to many small stretches of Ts present which could complement with a stretch of As generated 
by the ORF2p endonuclease action on the target region which in turn can be used as the second or “internal” 
primer leading to twin-priming, or (b) detection of more L1 insertions with these inversion properties than by 
conventional methods due to the sequencing of the whole inserted sequence. We were also able to sequence the 
entire source TTC28 L1 (Supplementary Fig. S4). In addition, we were able to identify that TTC28 3′ transduc-
tions terminated preferentially on two polyadenylation signals (Fig. 4), one predicted to be a true signal with the 
highest score (9th), and another defined as a false signal (6th) (Supplementary Table S2) by polyadq.
One insertion predicted by WGS was not identified in this study, however. LDI-PCR and Nanopore sequenc-
ing could have been hindered due to the formation of a secondary structure due to homology between the inser-
tion polyT and a nearby (567 bp upstream) polyA present in the reference genome.
LDI-PCR/Nanopore success principally relies on (i) a careful selection of the restriction enzymes so as to pro-
duce PCR-amplifiable target templates and (ii) the design of multiple primer pairs covering several downstream 
polyadenylation signals predicted by tools such as polyadq. In our initial pilot LDI-PCR/Nanopore sequencing 
experiment using one restriction enzyme (SacI) and two primer pairs on one sample (c985T), we were able to 
detect only 4 insertions out of 8 detected by WGS analysis. Detection sensitivity was substantially improved by 
updated sequencing chemistry, the use of two additional restriction enzymes and by designing more primers that 
covered additional polyadenylation signals in a well-dispersed manner.
LDI-PCR follows a similar targeting strategy as transduction-specific ATLAS (TS-ATLAS)18. However, 
LDI-PCR allows the amplification of both 5′ and 3′ junctions and sequencing the entire insertion simultaneously, 
which cannot be accomplished by any other L1 targeted approach or by WGS. The only region that remains 
unsequenced in a single read is the nucleotide bases in between the primer pairs, however this limitation can be 
minimized by reducing the distance between the primers and using more than one set of primers. Furthermore, 
the inverse PCR primers at the unique sequence enable the detection of L1 orphan transductions, which are not 
detected by other targeted sequencing techniques such as ATLAS, L1-seq, RC-seq or TIP-seq.15–17,19. Additionally, 
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LDI-PCR/Nanopore sequencing is customizable for any full-length L1 allowing the implementation of this assay 
on a handful of “hot” L1 elements that contributes to a large fraction of 3′ transductions in a cancer genome11.
To conclude, we demonstrated that LDI-PCR/ Nanopore sequencing is suitable for sequencing the entire 
L1 insertion and for detecting highly subclonal events. Consequently, applying LDI-PCR in conjunction with 
Nanopore sequencing in larger sample sets and different tumour types enables a more detailed characterization 
of L1 insertions providing new insights into L1 biology and cancer genetics.
Material and Methods
Samples. The colorectal adenocarcinoma (CRC) samples utilized in this study were obtained from a popula-
tion based series of 1042 CRCs previously described25,26. The tumours were fresh frozen and the corresponding 
normal tissues were obtained from blood (c985T) and from colon tissue (c368T). The study was reviewed and 
approved by the Ethics committee of the Hospital district of Helsinki and Uusimaa, Finland. A signed informed 
consent or authorization from the National Supervisory Authority for Welfare and Health was obtained for all 
the samples.
LDI-PCR and Nanopore sequencing. Digestion and ligation of DNA. To detect insertions arising from 
TTC28 L1, genomic DNA was separately digested by three restriction enzymes: SacI, PstI and NsiI. SacI and PstI 
make a 5′ cut at ORF1 of the L1 and a 3′ cut downstream of the unique tag producing a native restriction fragment 
of 5.7 kb and 6.3 kb respectively, whereas NsiI makes a 5′ cut 3.1 kb upstream of the intact L1 sequence and a 3′ 
cut downstream of the unique tag generating a native restriction fragment of ~10.2 kb (Fig. 1b, Supplementary 
Table S5). L1 retrotransposition usually involves a 5′ truncation, and the average L1 insert size including the 3′ 
transduced region is 1000 bp11. Therefore it is unlikely that the somatically acquired L1 insertion will contain 
the same SacI or PstI cut sites as the source region, hence increasing the likelihood that the target site restriction 
fragment is of different size compared to the native one. The infrequent cases of full-length somatic L1 insertion 
can be captured by the digestion library produced by NsiI. At least one out of three enzymes always generated 
a predicted restriction fragment of less than 8.2 kb in all the WGS predicted targets (Supplementary Table S5). 
Digested DNA was then self-ligated using T4 DNA ligase (Thermo) to form circular templates for LDI-PCR.
Primer Design and Optimization. Inverse primers for LDI-PCR were designed on the unique tag, that is, the 
genomic region between the canonical polyadenylation signal of the L1 and the next strongest polyadenylation 
signal on its 3′ flanking region (Fig. 1b, Supplementary Table S2). Strength of polyadenylation signals at this 
region was estimated using polyadq scores23 (http://rulai.cshl.edu/tools/polyadq/polyadq_form.html). Primers 
were designed using Primer3 (http://primer3.ut.ee) and their specificity was checked using NCBI Primer-BLAST 
(available at http://www.ncbi.nlm.nih.gov/tools/primer-blast/). Since there were several polyadenylation signals 
at the 3′ flanking region of the L1 (Fig. 1b), we designed several primer pairs between the canonical polyadeny-
lation signal (marked 1) and following downstream polyadenylation signals. Distance between the primers was 
kept as short as possible (≤51bp).
LDI-PCR. 1.25 ng circular templates generated by restriction enzyme digestion and T4 ligation were used 
in LDI-PCR as eight replicates (Supplementary Fig. S5) as previously described20 using three primer pairs 
(Supplementary Table S1). These PCR products were then analysed on a 1% agarose gel and purified using 
NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel). Replicate reactions showing reproducible patterns of 
PCR amplification were pooled, and sequenced using MinION (Oxford Nanopore Technologies). Replicates that 
did not show reproducibile patterns were discarded and the reaction was repeated again.
Oxford Nanopore MinION™ sequencing. LDI-PCR products from 18 different reactions (with three different 
primer pairs, three different restriction enzymes and from two tumour samples) were pooled into nine different 
barcodes in equal molarity. Tape Station 2200 (Agilent Technologies) was used to estimate the relative molar-
ity based on the fragment distribution in each reaction. Libraries were constructed according to the manufac-
turer’s instructions using SQK-LSK108 and EXP-NBD103 sequencing and barcoding kits (Oxford Nanopore 
Technologies). Equal molarity was preserved throughout the protocol. The MinION Flow cell (FLO-MIN106) 
was run for 6 hours using MinION Mk1B. The raw signal from MinION was basecalled with ONT Albacore 
Sequencing Pipeline Software (version 1.0.2). The reads passing base calling were aligned to GRCh37 genome 
reference augmented with viral and 1000 genomes decoy sequences. The alignment was performed with bwa 
mem v0.7.12 using option -x ont2d27.
LDI- PCR software. We separated the reads produced by different samples, PCR primers and restriction 
enzymes by using the sequencing barcodes and comparing the read mapping with restriction enzyme cut sites 
in the reference genome. To systematically detect the insertions, we developed the LDI-PCR.py software which 
identifies reads that display hallmark features of LDI-PCR products (Fig. 1b). Hallmarks of a LDI-PCR product 
in this experiment are: that it contains at least one alignment to TTC28 L1 (22:29060420–29067335) and at least 
one alignment to a single target locus in the genome. The read can have multiple supplementary alignments to 
the target locus but only if located in close proximity of each other (maximum distance between alignments 100 
kb). All considered alignments had to have mapping quality of at least 20. The insertion breakpoint was defined 
by the location where the alignment switched from TTC28 L1 to the target locus and vice versa for each hallmark 
read. All insertion breakpoints were clustered together allowing a maximum gap of 3 kb from all reads defining 
the different insertion locations. The most frequent genomic coordinate was called as the insertion breakpoint 
defining each LDI-PCR insertion call. The software is available at https://github.com/kpalin/LDI-PCR-call and 
https://github.com/kpalin/ampcorrect.
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Furthermore, LDI-PCR insertion calls had to be supported by at least 5 reads and, to filter away random 
ligation products generated by LDI-PCR, the insertion breakpoint had to be located at least 35 bp from the 
closest corresponding restriction enzyme cut site. Moreover, due to barcoding ligation crosstalk produced by 
EXP-NBD103 barcoding kit (Oxford Nanopore Technologies), several insertion calls were present in both sam-
ples. In order to circumvent this issue, in cases where the insertion call was present in two samples, only the calls 
coming from the sample that contained at least 95% of the reads were included in further analyses. Insertions in 
mitochondria and unplaced sequence were filtered away. All insertions that fulfilled the abovementioned criteria 
in at least one reaction were defined as candidate insertions and selected further for consensus sequence anal-
ysis of the insertion characteristics. The reads from the candidate insertions were processed with ampCorrect, 
a Nanopore read correction method similar to nanocorrect28, to obtain accurate consensus sequences for the 
amplicons. Briefly, ampCorrect uses sumaclust29 (http://metabarcoding.org/sumatra) to cluster the reads, requir-
ing 60% sequence similarity and poaV2 -do global30 to align multiple reads. The consensus sequence is treated 
as corrected sequence of the analysed amplicon. The processed sequences were aligned to the human reference 
genome using bwa mem with default parameters. The analysis of the insertion characteristics was performed on 
a consensus sequence which was constructed from 20 random candidate insertion call reads using UCSC BLAT 
(https://genome.ucsc.edu/cgi-bin/hgBlat) (Consensus sequence of all insertions analysed are provided in FASTA 
format in Supplementary dataset 1).
Determining the polyadenylation signal used for each L1 3′ transduction. Since the transcription termination and 
polyadenylation occurs 10–30 bp downstream of the selected polyadenylation signal31, we analysed how many 3′ 
coordinates of the L1 insertions were located within a 10–30 bp window downstream of each of the polyadenyl-
ation signal (stop signal window) located downstream of the L1 sequence (Supplementary Table S2). 9 out of 35 
L1 insertion terminal sequence did not fall within any of the 8 defined windows, and were assigned to the closest 
available window (maximum distance was 9 bp) (Table 1 and Supplementary Table S2).
Statistical analysis. To test for differences in read counts, we used Wilcoxon rank-sum test with continuity cor-
rection in R version 3.3.2. Read counts refer to numbers of reads supporting each candidate insertion called by 
LDI-PCR.py. In cases where the same candidate insertion was detected in different reactions (three different 
restriction enzymes and three different primer pairs) the reaction with higher read count was used.
Whole genome sequencing analysis. We utilized the WGS dataset described in Katainen et al.21 to 
select for LDI-PCR and Nanopore sequencing those colorectal cancer samples with a high number of somatically 
acquired insertions originating from TTC28. Structural variant breakpoints located at the 3′ end of the TTC28 L1 
were extracted to calculate the number of transductions. The 3′ end of the L1 was defined as GRCh37 coordinates 
22:29065455–29066124. To examine whether the novel candidate insertions were detected by WGS or not, we 
performed a thorough visual inspection of the paired-end read data using BasePlayer32.
In order to compare LDI-PCR Nanopore sequencing results to WGS data we performed local assembly of 
the WGS data. We selected those chimeric reads and discordant read pairs that aligned within 1kb upstream and 
downstream the predicted insertion breakpoint, with the exception of one insertion (chr15:97602708) where, due 
to a long target site deletion, a 3kb window was used. The local assembly of the reads was performed using Velvet 
1.2.1033. All hash lengths within default parameters (11,13,15,17,19,21,23,25,27,29,31) were tested and the hash 
length that produced the longest and most contiguous contig was selected for each insertion33 (Supplementary 
Table S4). We aligned the assembled contigs with UCSC Blat (https://genome.ucsc.edu/cgi-bin/hgBlat) to the 
GRCh37 genome reference.
Validation of highly subclonal L1 insertions by conventional PCR. Two approaches were used to 
validate novel candidate insertions detected by LDI-PCR but not by WGS: (i) First, primer pairs were designed 
on the target genomic region across the insertion breakpoint and sequenced by Nanopore. The library was pre-
pared as described in the section “Oxford Nanopore MinION™ sequencing”. This approach included all candi-
date subclonal insertions, however only 3/25 novel candidate insertions were validated (ii) Second, primers were 
designed based on the consensus sequence, with one primer at the target site and the other primer at the inserted 
sequence, followed by Sanger sequencing of the resulting PCR product; this was performed for 10 selected novel 
candidate insertions. Primer pairs were designed with primer3Plus (http://www.bioinformatics.nl/cgi-bin/prim-
er3plus/primer3plus.cgi). Primer sequences are in Supplementary Table S6. Sanger sequencing was performed by 
the Biomedicum Sequencing Unit, Helsinki, on ABI Prism 3130xl Genetic Analyzer (Applied Biosystems) using 
BigDye Terminator v3.1 cycle sequencing kit (Applied Biosystems). Sequences were manually analysed using 
FinchTV v.1.4.0 (http://www.freewarefiles.com/FinchTV_program_17782.html).
Data availability. The datasets generated during and analysed during the current study are available from 
the corresponding author on request.
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